|
47 Companies |
|
50 Products |
|
50 Products |
|
66 Mechanisms of Action |
|
0 Trials |
|
978 News |
|
| «12...45678910111213141516 |
- ||| Clinical: Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma (clinicaltrials.gov) - Feb 20, 2012
P=N/A, N=120, Recruiting, Sponsor: Denver Health and Hospital Authority
- || New P3 trial, Preclinical: Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease (clinicaltrials.gov) - Feb 18, 2012
P3, N=55, Completed, Sponsor: Kunming Medical University
- |||| Trial completion: ADVANCEIII: Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III (clinicaltrials.gov) - Feb 15, 2012
P4, N=1902, Completed, Sponsor: Medtronic Bakken Research Center
Active, not recruiting --> Completed
- | New P1/2 trial: Use of PiCCO System in Critically Ill Patients With Septic Shock and Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Feb 1, 2012
P1/2, N=400, Recruiting, Sponsor: Jinhua Central Hospital
- Trial completion: Study Comparing High Cut-off Haemofiltration With Standard Haemofiltration in Acute Renal Failure (clinicaltrials.gov) - Jan 25, 2012
P1/2, N=76, Completed, Sponsor: Austin Health
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment open: Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial (clinicaltrials.gov) - Jan 16, 2012
P=N/A, N=160, Recruiting, Sponsor: National University Hospital, Singapore
Recruiting --> Completed Not yet recruiting --> Recruiting
- | Enrollment open: The Cooling And Surviving Septic Shock Study (CASS) (clinicaltrials.gov) - Jan 11, 2012
P2/3, N=560, Recruiting, Sponsor: Danish Procalcitonin Study Group
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- irinotecan / Generic mfg.
Trial completion: Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea (clinicaltrials.gov) - Jan 4, 2012
P2, N=130, Completed, Sponsor: AHS Cancer Control Alberta
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment change: CPR: Pre-shock Cardiopulmonary Resuscitation to Patients With Out-of-hospital Resuscitation, A Randomised Clinical Trial (clinicaltrials.gov) - Jan 3, 2012
P=N/A, N=1666, Completed, Sponsor: National Taiwan University Hospital
Recruiting --> Completed N=200 --> 1666
- Trial termination: Avascular Necrosis (AVN) Long-Term Follow-up (clinicaltrials.gov) - Dec 19, 2011
P=N/A, N=35, Terminated, Sponsor: Zimmer, Inc.
N=200 --> 1666 Active, not recruiting --> Terminated
- |||| Trial completion: RAPTURE: The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock (clinicaltrials.gov) - Dec 14, 2011
P4, N=100, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Terminated Active, not recruiting --> Completed
- || New P3 trial: TRISS: Transfusion-requirements in Septic Shock Trial (clinicaltrials.gov) - Dec 1, 2011
P3, N=1000, Active, not recruiting, Sponsor: Scandinavian Critical Care Trials Group
- Trial completion: Cellulite and Extracorporeal Shock Wave (clinicaltrials.gov) - Nov 30, 2011
P=N/A, N=100, Completed, Sponsor: Hannover Medical School
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study) (clinicaltrials.gov) - Nov 30, 2011
P1/2, N=70, Completed, Sponsor: Sunnybrook Health Sciences Centre
Recruiting --> Completed Recruiting --> Completed
- Trial completion: The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH" (clinicaltrials.gov) - Nov 20, 2011
P=N/A, N=1011, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: A Study to Assess Safety,and Tolerability of 2 Doses of AZD9773 (CytoFab™) in Japanese With Severe Sepsis/Septic Shock (clinicaltrials.gov) - Nov 6, 2011
P2, N=20, Completed, Sponsor: AstraZeneca
Recruiting --> Completed Active, not recruiting --> Completed
- Biomarker: The Value of PSP in Predicting Outcome in ICU Surgical Peritonitis Patients (clinicaltrials.gov) - Oct 27, 2011
P=N/A, N=137, Enrolling by invitation, Sponsor: University of Magdeburg
- Enrollment open, Video: Pre Hospital Evaluation of Video Laryngoscopy (clinicaltrials.gov) - Oct 27, 2011
P4, N=262, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- || New P2/3 trial: The Cooling And Surviving Septic Shock Study (CASS) (clinicaltrials.gov) - Oct 17, 2011
P2/3, N=560, Recruiting, Sponsor: Danish Procalcitonin Study Group
- |||| Enrollment open: ISIS-ICD: Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination (clinicaltrials.gov) - Oct 16, 2011
P4, N=1000, Recruiting, Sponsor: Sorin Group
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion: Systemic Inflammation Versus Acute Pain in Total Knee Arthroplasty (TKA) (clinicaltrials.gov) - Oct 13, 2011
P=N/A, N=120, Completed, Sponsor: Hvidovre University Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment change: VaCoSS: Serial Vasopressin and Copeptin Levels in Children With Sepsis and Septic Shock (clinicaltrials.gov) - Oct 11, 2011
P=N/A, N=153, Recruiting, Sponsor: Jan Hau Lee
Recruiting --> Completed N=105 --> 153
- Clinical: Preemptive Resuscitation for Eradication of Septic Shock (clinicaltrials.gov) - Oct 6, 2011
P=N/A, N=140, Recruiting, Sponsor: Christiana Care Health Services
- | remifentanil / Generic mfg.
New P4 trial: Remifentanil in Extracorporeal Shock Wave Lithotripsy (clinicaltrials.gov) - Oct 5, 2011
P4, N=228, Completed, Sponsor: University of Roma La Sapienza
- | Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
New P4 trial: ADRENAL: ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock (clinicaltrials.gov) - Oct 5, 2011
P4, N=3800, Recruiting, Sponsor: The George Institute
- dexmedetomidine / Generic mfg.
Clinical: The Effects of Sedative on the Fluid Responsiveness in Critically Ill Patients (clinicaltrials.gov) - Oct 4, 2011
P1, N=100, Completed, Sponsor: Southeast University, China
- Enrollment change: Systemic Inflammation Versus Acute Pain in Total Knee Arthroplasty (TKA) (clinicaltrials.gov) - Sep 27, 2011
P=N/A, N=120, Completed, Sponsor: Hvidovre University Hospital
N=105 --> 153 N=80 --> 120
- Clinical: High MAP in Septic Shock With Hypertension (clinicaltrials.gov) - Sep 27, 2011
P=N/A, N=24, Recruiting, Sponsor: Southeast University, China
- TV003 / Medigen Biotech, National Institute of Allergy and Infectious Diseases, TV005 / National Institute of Allergy and Infectious Diseases
New P1 trial, IO biomarker: Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine (clinicaltrials.gov) - Sep 15, 2011
P1, N=112, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- New P1/2 trial: Ascorbic Acid (Vitamin C) Infusion in Human Sepsis (clinicaltrials.gov) - Sep 12, 2011
P1/2, N=24, Completed, Sponsor: Virginia Commonwealth University
- || Trial completion: LI-ESWT: The Effect of Low Intensity Shockwave Therapy for ED in Post Radical Prostatectomy Patients Who Didn't Respond to PDE5i (clinicaltrials.gov) - Sep 12, 2011
P3, N=20, Completed, Sponsor: Rambam Health Care Campus
N=80 --> 120 Recruiting --> Completed
- Trial completion: PROTEOHSEPS: Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients (clinicaltrials.gov) - Sep 12, 2011
P=N/A, N=60, Completed, Sponsor: Institut Paoli-Calmettes
Recruiting --> Completed Recruiting --> Completed
- | New P4 trial: Extracorporeal Shock Wave Treatment - Can the Pain be Reduced? (clinicaltrials.gov) - Sep 5, 2011
P4, N=100, Recruiting, Sponsor: University of Zurich
- |||| Trial completion: BaSES Trial: Basel Starch Evaluation in Sepsis (clinicaltrials.gov) - Aug 10, 2011
P4, N=231, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed Recruiting --> Completed
- |||||||||| New P3 trial: Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock (clinicaltrials.gov) - Aug 9, 2011
P3, N=71, Completed, Sponsor: Innogene Kalbiotech Pte. Ltd